UNIGE document Scientific Article
previous document  unige:93784  next document
add to browser collection
Title

Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient
Authors
Andrey, Diego Olivier
Kaiser, Laurent
Emonet, Stéphane
Erard, Veronique
Chalandon, Yves
Van Delden, Christian
Published in International Journal of Infectious Diseases. 2017, vol. 55, p. 24-26
Abstract Mucormycosis (zygomycosis) is an emerging fungal disease in allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients. A 30-year-old woman diagnosed with acute myelomonocytic leukemia and needing allo-HSCT presented pulmonary and cerebral infection due to Rhizomucor pusillus. This fungal infection was treated with surgical treatment and posaconazole delayed-release tablets. This strategy allowed reaching high drug levels that could not be obtained with the posaconazole solution.
Keywords Mucormycosis — Posaconazole delayed-release tablets — Rhizomucor pusillus — Zygomycosis
Identifiers
PMID: 27988409
Full text
Article (Published version) (389 Kb) - public document Free access
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Faculté de médecine / Section de médecine clinique / Département de chirurgie
Research groups Transplantation et hépatologie (905)
Groupe Laurent Kaiser (virologie clinique) (668)
Leucémie et transplantation allogénique de cellules souches hématopoïétiques (982)
Quorom-sensing et gènes de virulence (301)
Citation
(ISO format) 		ANDREY, Diego Olivier et al. Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient. In: International Journal of Infectious Diseases, 2017, vol. 55, p. 24-26. doi: 10.1016/j.ijid.2016.12.014 https://archive-ouverte.unige.ch/unige:93784

297 hits

47 downloads

Contact an author

Update request

Update

Deposited on : 2017-04-21

Export document
Format :
Citation style :